Key Decisions for Life Science Companies: Stay the Course or Exit via M&A?
By Andrew Levitch, Mark Murray, Patrick Nugent, Linda Rubinstein
This article is the fourth in a 4-part series reviewing financing solutions for the Life Science sector. Many life science companies are fortunate to reach a critical inflection point where leadership must face a decision: continue to fund growth to reach clinical milestones independently or exit via merger and acquisition….Read More
Read MoreHow Better Financial Planning Drives Value and Growth
By Bill Leetham
Finance and accounting teams wear many hats in any organization. At the most fundamental level, they make sure the business has enough cash to pay vendors and employees while allowing the business to meet the objectives of its shareholders, be that for growth or strong cash flow. In earlier posts,…Read More
Read MoreCFOs as Drivers of Influence
By Jonathan Wolter
I was recently in a discussion with an acquaintance who asked, “As a CFO, what do you spend most of your time doing?” Reflecting a moment, I responded “I seem to spend a lot of my time either (1) persuading people to do something that they’d rather not do, or…Read More
Read More